Donald Strickland, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
University of Missouri - Kansas City
Medical School
Children's Mercy Hospital
Residency
Duke University Hospital
Fellowship
American Board of Internal Medicine - Oncology
TN State Medical License: 1997 - 2017
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Rudin, C. M.,Pietanza, M. C.,Bauer, T. M.,Ready, N.,Morgensztern, D.,Glisson, B. S.,Byers, L. A.,Johnson, M. L.,Burris, H. A.,Robert, F.,Han, T. H.,Bheddah, S.,Theiss,...; Lancet Oncol.. 2016 Dec 10.
See more >>57 citations The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort.
Castellino, S., Lensing, S., Riely, C., Rai, S.N., Davila, R., Hayden, R.T., Fleckenstein, J., Levstik, M., Taylor, S., Dean, P.J., Kippenbrock, S., Pope, J., Carr, J....; Blood. 2004 Apr 1.
See more >>45 citations Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature.
Gow, K.W., Lensing, S., Hill, D.A., Krasin, M.J., McCarville, M.B., Rai, S.N., Zacher, M., Spunt, S.L., Strickland, D.K., Hudson, M.M.; J Pediatr Surg. 2003 Nov.
See more >>